NumFin

Vitrolife AB (publ)

Sümbol: VITR.ST

STO

178.2

SEK

Turuhind täna

  • -6.2897

    P/E suhe

  • 0.4403

    PEG suhe

  • 24.13B

    MRK Cap

  • 0.01%

    DIV tootlus

Vitrolife AB (publ) (VITR-ST) Finantsaruanded

Download
AastaneQuarterly
LineaarneLog
Diagrammil näete Vitrolife AB (publ) (VITR.ST) vaikimisi numbreid dünaamikates. Companys revenue näitab keskmist NaN M, mis on NaN % gowth. Kogu perioodi keskmine brutokasum on NaN M, mis on NaN %. Keskmine brutokasumi suhtarv on NaN %. Ettevõtte eelmise aasta tulemuse puhaskasv on NaN %, mis on võrdne NaN % % keskmiselt kogu ettevõtte ajaloo jooksul.,

AastaneQuarterly
10Y20Y30Y40Y

Bilanss

Sukeldudes Vitrolife AB (publ) fiskaalkäiguteele, täheldame keskmist varade kasvu. See määr on huvitaval kombel , mis kajastab nii ettevõtte kõrg- kui ka madalseisusid. Kui võrrelda kvartalite lõikes, siis kohandub see näitaja . Kui vaadata tagasi möödunud aastale, siis on varade kogumuutus NaN. Aktsionäride väärtus, mida näitab aktsionäride kogu omakapital, on hinnatud NaN aruandlusvaluutas. Selle aspekti aastane muutus on NaN%.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002

balance-sheet.row.cash-and-short-term-investments

0861578630.1
973.6
689.5
490.8
396
189.2
199.6
107.6
53.8
11.7
20.9
18.6
16
14
18.5
14.5
48.3
44.9
0
0

balance-sheet.row.short-term-investments

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.net-receivables

0583542463.6
236.8
240.2
0
0
0
0
0
0
0
0
0
0
0
29.8
29.1
17.2
13.7
0
0

balance-sheet.row.inventory

0413405312.9
204
208.8
161.2
150.6
145.7
102.3
91.7
59.9
62.4
65.7
56.6
41.8
46.2
40.4
28.3
24.8
21.9
21.5
18.6

balance-sheet.row.other-current-assets

057470
0
11.7
198.6
163.4
141.6
112.6
109.5
73.6
68.7
66.9
56.3
46
44.9
3.2
3.2
1.6
2.5
52.4
50.5

balance-sheet.row.total-current-assets

0191415721406.6
1414.4
1150.2
850.6
709.9
476.5
414.5
308.8
187.3
142.8
153.4
131.6
103.8
105.2
91.9
75.1
91.9
83.1
88
79.5

balance-sheet.row.property-plant-equipment-net

0349318333
142.1
173.4
94.1
84.4
93.7
89.6
92.3
86
94.4
95.4
91.3
93
94.8
76.6
81.7
88.8
18.4
19.2
21.7

balance-sheet.row.goodwill

095911387412994.6
403.2
425.8
421.6
408.9
403.2
350.5
364.5
183.3
182.1
0
120.3
0
0
83.3
83.3
4
3.3
4
4.7

balance-sheet.row.intangible-assets

0431246484552.9
299.5
352.4
306.4
198.8
245.9
165
196.8
23
33.9
0
65.3
0
0
24
24.7
3.8
0
0
0

balance-sheet.row.goodwill-and-intangible-assets

0139031852217547.5
702.7
778.3
728
607.7
649.1
515.5
561.4
206.3
216
204.4
185.6
131.8
115
107.3
107.9
7.8
3.3
4
4.7

balance-sheet.row.long-term-investments

0503649.2
39.5
32.7
23.6
0
0
0
0
5.4
3.2
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.tax-assets

017310292.5
6.4
4.2
1.2
11.2
22.3
30
0
2.8
5.7
11.1
18.3
30.7
27.7
23.7
6.3
5.9
6.3
6.1
0.9

balance-sheet.row.other-non-current-assets

0200
0
0
0
9.2
8.9
9.7
10
0
0
2.3
2.6
0
0
0
0
16.9
74.5
66.7
81.6

balance-sheet.row.total-non-current-assets

0144771897818022.2
890.6
988.5
846.9
712.5
774
644.8
663.7
300.5
319.4
313.3
297.8
255.5
237.5
207.6
195.9
119.5
102.5
96
109

balance-sheet.row.other-assets

0010
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-assets

0163912055119428.8
2305.1
2138.7
1697.5
1422.4
1250.5
1059.2
972.5
487.8
462.2
466.8
429.4
359.3
342.7
299.5
271
211.4
185.5
184
188.5

balance-sheet.row.account-payables

0171181173.1
25.9
29.3
32.1
30.6
24.3
21.7
22.3
15.6
17.4
19.9
26.6
14.7
23.5
9.5
9.2
7.3
8.7
6.4
9.6

balance-sheet.row.short-term-debt

0147182455.7
13.6
14.6
0
0.1
37.4
11.9
25.8
17
16.8
5.4
20.4
3
3.2
0
0
0
0
0
0

balance-sheet.row.tax-payables

0192726.5
9.6
30.4
29.7
22
27.2
40.2
38.3
17.3
9.9
3.4
0
0
0
0
0
0
0
0
0

balance-sheet.row.long-term-debt-total

0187520432026.8
48.8
61.2
0
0.4
0.5
35.6
60
21.6
58.2
61.5
31.8
7.2
3.3
0
0
0
0
0
0

Deferred Revenue Non Current

033027.5
21.5
16.6
0
0
0
0
4
4.3
1.1
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.deferred-tax-liabilities-non-current

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.other-current-liab

018721258.8
24.7
18.5
120.2
12.8
12.7
4.4
9.5
10.7
5.2
9.1
2.5
2.7
2.2
21.8
19.4
12.1
10.2
14.6
39.6

balance-sheet.row.total-non-current-liabilities

0311131903133.6
111.1
138.7
49
58.9
70.8
82.9
110.1
65.5
103
61.5
31.8
7.2
3.3
14.7
21.8
15.6
16.1
19.6
27.9

balance-sheet.row.other-liabilities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.capital-lease-obligations

06784109.4
62.4
75.8
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.total-liab

0366838114087.9
288.1
341.1
201.3
193.8
230.1
214.3
269.9
165.2
183.2
122.9
103.1
47.2
50.3
46.1
50.4
34.9
35
40.6
77.1

balance-sheet.row.preferred-stock

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.common-stock

0282827.6
22.1
22.1
22.1
22.1
22.1
22.1
22.1
20.2
20.2
20
19.9
19.9
19.8
19.8
19.8
18.4
18.4
18.4
18.4

balance-sheet.row.retained-earnings

0-199320001730
1493.9
1216.4
925.9
696.5
489.3
351.1
200.8
118.6
74.2
137.8
120.6
101.5
75.2
51.2
15.1
0.1
11.9
44.7
116.5

balance-sheet.row.accumulated-other-comprehensive-income-loss

01144116420.6
1.9
60.8
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

balance-sheet.row.other-total-stockholders-equity

0135431354413544
494.6
494.6
544.9
507.2
506.6
469.9
478
182.1
183.3
185.3
185.1
190.2
197.1
182.4
185.7
158
120.2
80.4
-23.5

balance-sheet.row.total-stockholders-equity

0127221673615322.2
2012.6
1794
1492.9
1225.9
1018.1
843.2
700.9
321
277.8
343
325.7
311.6
292.1
253.4
220.6
176.4
150.6
143.4
111.4

balance-sheet.row.total-liabilities-and-stockholders-equity

0163912055119428.8
2305.1
2138.7
1697.5
1422.4
1250.5
1059.2
972.5
487.8
462.2
466.8
429.4
359.3
342.7
299.5
271
211.4
185.5
184
188.5

balance-sheet.row.minority-interest

01418.7
4.4
3.6
3.3
2.8
2.3
1.8
1.7
1.6
1.2
0.9
0.7
0.5
0.3
0
0
0
0
0
0

balance-sheet.row.total-equity

0127231674015340.9
2017
1797.6
1496.2
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

balance-sheet.row.total-liabilities-and-total-equity

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

Total Investments

0503649.2
39.5
32.7
23.6
9.2
8.9
9.7
10
5.4
3.2
2.3
2.6
0
0
0
0
0
0
0
0

balance-sheet.row.total-debt

0208922252482.5
62.4
75.8
0
0.5
37.9
47.5
85.8
38.6
75.1
67
52.2
10.2
6.5
0
0
0
0
0
0

balance-sheet.row.net-debt

0122816471852.4
-911.2
-613.7
-490.8
-395.5
-151.4
-152.1
-21.8
-15.1
63.4
46.1
33.6
-5.8
-7.5
-18.5
-14.5
-48.3
-44.9
0
0

Rahavoogude aruanne

Vitrolife AB (publ) finantsmaastikul on viimase perioodi jooksul toimunud märkimisväärne muutus vabas rahavoos, mis näitab NaN nihet. Ettevõte laiendas hiljuti oma aktsiakapitali, emiteerides NaN, mis tähistab NaN erinevust võrreldes eelmise aastaga. Ettevõtte investeerimistegevuse tulemusel kasutas ettevõte netosularaha, mis aruandlusvaluutas oli NaN. See on NaN nihkumine võrreldes eelmise aastaga. Samal perioodil registreeris ettevõte NaN, NaN, NaN, mis on olulised ettevõtte investeerimis-ja tagasimaksestrateegiate mõistmiseks. Ettevõtte finantseerimistegevuse tulemusel kasutas ettevõte netorahavahendeid NaN, kusjuures erinevus võrreldes eelmise aastaga oli NaN. Lisaks eraldas ettevõte NaN aktsionäridele dividendide maksmiseks. Samal ajal tegi ta muid finantsmanöövreid, millele viidatakse kui NaN, mis samuti mõjutasid oluliselt tema rahavooge sel perioodil. Need komponendid koos annavad tervikliku pildi ettevõtte finantsseisundist ja strateegilisest lähenemisest rahavoogude juhtimisele.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002

cash-flows.row.net-income

0-3851537460
366.2
492.7
398.6
340.9
248.9
226.8
146.9
79.8
352.9
45.1
41.3
30.6
27.2
36.1
15.2
14.9
11.9
44.7
116.5

cash-flows.row.depreciation-and-amortization

0425396108.9
84.1
99.4
84.7
66.9
54.3
53.1
23.3
34.9
18.2
0
0
0
0
0
0
0
0
0
0

cash-flows.row.deferred-income-tax

0-9860-181.1
-95.9
0
0
0
0
0
0
0
-303.9
0
0
0
0
0
0
0
0
0
0

cash-flows.row.stock-based-compensation

017104.8
1.5
0
0
0
0
0
0
0
0.2
0
0
0
0
0
0
0
0
0
0

cash-flows.row.change-in-working-capital

0-119-175-10.2
9.8
-61.6
-34.7
-10.1
-39.4
-20.8
5.3
1
-8.2
-19.5
-6.8
-3.2
4.7
18
7.4
1.8
2.5
11.5
0.3

cash-flows.row.account-receivables

0-95-56-5.5
14.9
-48.5
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.inventory

0-15-71-46.9
-4.4
-44.3
-4.5
-8.5
-26.3
-9.8
5.5
2.5
0.1
-7.9
-12.6
3.1
-0.9
14.9
0.4
2.1
0.5
3.7
2.7

cash-flows.row.account-payables

0-9-4842.2
-0.6
31.2
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.other-working-capital

0000
0
0
-30.3
-1.6
-13.1
-11.1
-0.2
-1.5
-8.3
-11.6
5.7
-6.3
5.6
3.1
7
-0.3
2
7.8
-2.4

cash-flows.row.other-non-cash-items

05271-1321.9
-9.2
-117.1
-99.1
-85.6
-82.6
-65.5
-29.8
-9.6
0.6
13.8
14
14.1
10.9
-32.8
1.2
-2.6
-0.4
-24.9
-82

cash-flows.row.net-cash-provided-by-operating-activities

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

cash-flows.row.investments-in-property-plant-an-equipment

0-120-87-62.4
-20.1
-87.1
-180.1
-10.5
-13.8
-22.6
-8.9
-8.5
-17.4
-37.8
0
-24.9
-40.3
-6.2
-7.7
-7
-14.6
-0.5
-54.3

cash-flows.row.acquisitions-net

0-4-42-6466.2
0.2
-23.8
0
0
-116.5
-9.1
-67.8
-1.9
-31.5
0
-36.9
-8.1
-5.4
0
69.1
5
0
0
0

cash-flows.row.purchases-of-investments

000-0.4
-0.4
-2
-1.7
0
-0.7
13.1
-0.8
-4
0
0
-41.2
0
0
0
3.9
-0.2
0
0
0

cash-flows.row.sales-maturities-of-investments

00016.2
-0.2
68
0
0.2
3.8
0.4
2.9
0
0
0
0
0
0
0
5.2
3.2
0
0
0

cash-flows.row.other-investing-activites

00-15-5.7
0.2
-67.7
0.5
0.3
-3.8
-13.1
-2.9
0
-13.7
0
0
0
19.2
16.8
8.7
8
32.5
57.3
103.1

cash-flows.row.net-cash-used-for-investing-activites

0-124-144-6518.5
-20.2
-112.6
-181.3
-10
-131
-31.4
-77.5
-14.4
-62.5
-37.8
-78.1
-33
-26.6
10.6
79.1
9
17.9
56.8
48.8

cash-flows.row.debt-repayment

0-154-448-1.9
-15.8
-14.6
-0.5
-37.3
-12.3
-36.6
-59.7
-31.5
-15.3
-2.4
-3
0
-15.3
0
0
0
0
0
0

cash-flows.row.common-stock-issued

0003558.3
-10.8
0
0
0
0
0
0
0
0
0.3
0
0
0
0
0
0
0
0
0

cash-flows.row.common-stock-repurchased

000-22.8
0
0
0
0
0
0
0
0
0
20.3
0
0
-6.4
0
0
0
0
0
0

cash-flows.row.dividends-paid

0-115-110-88.3
0
-92.3
-81
-57
-52.5
-32.8
-20.2
-11.9
-13.8
-11.7
0
-7.8
0
0
0
0
0
0
0

cash-flows.row.other-financing-activites

0-31-242303.4
-10.8
-14.6
0
0.9
1.3
0.5
60.3
-5.8
23.5
-6.1
35.8
1.4
0.3
6.5
21.7
2
2.6
8.4
13.3

cash-flows.row.net-cash-used-provided-by-financing-activities

0-300-5825748.7
-26.6
-106.9
-81.5
-93.5
-63.6
-68.9
-19.7
-49.2
-5.6
0.4
32.8
-6.4
-21.4
6.5
21.7
2
2.6
8.4
13.3

cash-flows.row.effect-of-forex-changes-on-cash

0-503942
-25.6
4.9
8.1
-2
3
-1.2
5.4
-0.4
-1
0.2
-0.5
-0.2
0.7
0.1
0.2
0.3
0.1
2.1
2.6

cash-flows.row.net-change-in-cash

0283-52-343.5
284
198.7
94.8
206.7
-10.3
92
53.8
42.1
-9.2
2.3
2.6
2
-4.5
4
-33.8
3.4
-6.6
15.2
-99.5

cash-flows.row.cash-at-end-of-period

0861578630.1
973.6
689.5
490.8
396
189.2
199.6
107.6
53.8
11.7
20.9
18.6
16
14
18.5
14.5
48.3
44.9
51.5
36.4

cash-flows.row.cash-at-beginning-of-period

0578630973.6
689.5
490.8
396
189.2
199.6
107.6
53.8
11.7
20.9
18.6
16
14
18.5
14.5
48.3
44.9
51.5
36.4
135.9

cash-flows.row.operating-cash-flow

0757636384.3
356.4
413.3
349.4
312.2
181.3
193.5
145.7
106.1
59.9
39.5
48.4
41.5
42.8
21.3
23.8
14.1
14
31.2
34.8

cash-flows.row.capital-expenditure

0-120-87-62.4
-20.1
-87.1
-180.1
-10.5
-13.8
-22.6
-8.9
-8.5
-17.4
-37.8
0
-24.9
-40.3
-6.2
-7.7
-7
-14.6
-0.5
-54.3

cash-flows.row.free-cash-flow

0637549321.9
336.4
326.2
169.3
301.7
167.5
170.9
136.7
97.6
42.6
1.6
48.4
16.6
2.4
15.1
16.1
7.1
-0.6
30.7
-19.6

Kasumiaruande rida

Vitrolife AB (publ) tulud muutusid võrreldes eelmise perioodiga NaN%. VITR.ST brutokasum on teatatud NaN. Ettevõtte tegevuskulud on NaN, mille muutus võrreldes eelmise aastaga on NaN%. Kulud amortisatsioonikulud on NaN, mis on NaN% muutus võrreldes eelmise aruandeperioodiga. Tegevuskulud on teatatud NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Müügi- ja turunduskulud on NaN, mis on NaN% muutus võrreldes eelmise aastaga. Hiljutistel numbritel põhinev EBITDA on NaN, mis tähendab NaN% kasvu võrreldes eelmise aastaga. Tegevustulu on NaN, mis näitab NaN% muutust võrreldes eelmise aastaga. Puhaskasumi muutus on NaN%. Eelmise aasta puhaskasum oli NaN.

common:word.in-mln

USD
Growth
TTM2023202220212020201920182017201620152014201320122011201020092008200720062005200420032002

income-statement-row.row.total-revenue

0351232341680.8
1245.6
1480.1
1151.3
1046.2
856.1
722.4
510.5
452.7
362
356.1
297.6
274.6
225.1
188.9
171.3
120.1
103.9
96.3
103.3

income-statement-row.row.cost-of-revenue

017741454634.7
477.9
541.5
390.2
364.5
294.8
237.6
161.4
152.2
123.7
117.8
91.4
81.7
68.9
59.3
54.7
37.2
29.5
34.6
53.9

income-statement-row.row.gross-profit

0173817801046.1
767.7
938.7
761.1
681.7
561.3
484.8
349.1
300.6
238.3
238.3
206.2
192.9
156.3
129.7
116.5
82.9
74.4
61.6
49.4

income-statement-row.row.gross-profit-ratio

0000
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0
0

income-statement-row.row.research-development

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-general-administrative

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-expenses

00121.5
-11.3
0
-0.2
-0.4
1.7
0.4
0.9
2.5
0.9
1
-39.8
4.8
-1.9
-0.1
0.7
-4.3
0.3
-43.6
-165.7

income-statement-row.row.operating-expenses

010051145619.7
391.9
450.5
372.1
338.4
313.1
276.3
213.3
221.7
188.2
197.1
173.1
162.5
129.1
108.6
96.5
70.9
61.3
19.8
-73.1

income-statement-row.row.cost-and-expenses

0277925991254.4
869.8
991.9
762.3
702.9
607.9
513.8
374.7
373.9
311.9
315
264.5
244.2
198
167.9
151.2
108.1
90.8
54.4
-19.1

income-statement-row.row.interest-income

01620.8
0.8
1.5
1.3
0.3
0.4
0.3
0.3
0.4
10.2
0
0
0
0
4.9
6.5
3.7
0
7.1
2.3

income-statement-row.row.interest-expense

0944410.4
2.1
2.3
0.5
0.4
0.8
1.2
1
1.8
10.2
0
9.6
0
0
2.3
1.6
6.9
0
4.8
7.9

income-statement-row.row.selling-and-marketing-expenses

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.total-other-income-expensenet

0-4445-11724.6
-3.8
4.7
9.5
-2.4
0.7
18.3
11.1
1
-0.4
3.9
8.2
0.2
0.1
-2.6
-5
3.2
-1.3
-2.4
-5.6

income-statement-row.row.ebitda-ratio-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.other-operating-expenses

00121.5
-11.3
0
-0.2
-0.4
1.7
0.4
0.9
2.5
0.9
1
-39.8
4.8
-1.9
-0.1
0.7
-4.3
0.3
-43.6
-165.7

income-statement-row.row.total-operating-expenses

0-4445-11724.6
-3.8
4.7
9.5
-2.4
0.7
18.3
11.1
1
-0.4
3.9
8.2
0.2
0.1
-2.6
-5
3.2
-1.3
-2.4
-5.6

income-statement-row.row.interest-expense

0944410.4
2.1
2.3
0.5
0.4
0.8
1.2
1
1.8
10.2
0
9.6
0
0
2.3
1.6
6.9
0
4.8
7.9

income-statement-row.row.depreciation-and-amortization

0425341141.7
73.8
107
84.7
66.9
54.3
53.1
23.3
34.9
18.2
0.5
17.8
0
0
-0.4
-3.4
10.1
0
2.4
2.3

income-statement-row.row.ebitda-caps

0---
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-
-

income-statement-row.row.operating-income

0733654435.4
370
487.9
393.9
340.9
248.8
226.1
143.3
80.4
49.7
40.9
33.1
30.4
27.1
21
20
12.1
13
41.9
122.4

income-statement-row.row.income-before-tax

0-3712537460
366.2
492.7
398.6
340.9
248.9
226.8
146.9
79.8
49.7
45.1
41.3
30.6
27.2
18.4
15
15.3
11.7
39.5
116.8

income-statement-row.row.income-tax-expense

0139143116.4
78.3
108.9
87.9
76.3
57.7
43.5
37.5
23.1
23.2
14.5
12.1
-3.8
-3
-17.7
-0.2
-0.4
-0.2
-5.2
-0.6

income-statement-row.row.net-income

0-3851394341
286.8
382.8
309.7
263.6
190.4
182.8
109.1
56.3
333.8
30.4
29.2
34.1
30
36.1
15.2
14.9
11.9
44.7
116.5
Sarnased aktsiad
Sind võib huvitada ka:
EW
Edwards Lifesciences Corporation.
87.42 USD
NYSE
SOFW.TA
SofWave Medical Ltd..
1778 ILA
TLV
BIOL
BIOLASE, Inc..
0.1739 USD
NASDAQ
4549.T
Eiken Chemical Co., Ltd..
2002 JPY
JPX
USAQ
QHSLab, Inc..
0.08685 USD
PNK
QLIFE.ST
Qlife Holding AB (publ).
0.003 SEK
STO
LFWD
ReWalk Robotics Ltd..
5.16 USD
NASDAQ
BBLG
Bone Biologics Corporation.
1.8001 USD
NASDAQ
300298.SZ
Sinocare Inc..
23.32 CNY
SHZ
HYPR
Hyperfine, Inc..
0.7971 USD
NASDAQ

Korduma kippuv küsimus

Mis on Vitrolife AB (publ) (VITR.ST) koguvara?

Vitrolife AB (publ) (VITR.ST) koguvara on 16391000000.000.

Mis on ettevõtte aastane tulu?

Aastane tulu on N/A.

Mis on ettevõtte kasumimarginaal?

Ettevõtte kasumimarginaal on 0.528.

Mis on ettevõtte vaba rahavoog?

Vaba rahavoog on 4.823.

Mis on ettevõtte puhaskasumimarginaal?

Puhaskasumimarginaal on -1.097.

Mis on ettevõtte kogutulu?

Kogutulu on 0.206.

Mis on Vitrolife AB (publ) (VITR.ST) puhaskasum (puhaskasum)?

Puhaskasum (netotulu) on -3851000000.000.

Kui suur on ettevõtte koguvõlg?

Koguvõlg on 2089000000.000.

Mis on tegevuskulude arv?

Tegevuskulud on 1005000000.000.

Milline on ettevõtte rahaline näitaja?

Ettevõtte raha on 0.000.